藥碼
HEP02
藥名
Hepatitis B immune globulin
英文商品名
自費 兒 HyperHEP HBIG 0.5 mL
中文商品名
B型肝炎免疫人血球蛋白注射液
螢幕名
自費 兒 HyperHEP HBIG 0.5 mL
劑型
Inj
規格
0.5ml 新生兒 HyperHEP-B (HBIG)
成分
藥理分類
Serums
健保碼
KC00452206
ATC碼
藥品圖片
外觀圖片
適應症
Hepatitis B, Post-exposure; Prophylaxis
藥理
1.Hepatitis B, Postexposure; Prophylaxis household exposure in infants less than 12 months of age, acute hepatitis B infection in mother or primary caregiver: 0.5 mL IM as a single dose plus hepatitis B vaccine. 2.HepaGam B(R), Nabi-HB(R) (perinatal transmission prophylaxis in infants born to HBsAg-positive mothers) 0.5 mL IM within 12 hours of birth plus appropriate hepatitis B vaccine series [3][5]; for infant born to mothers not screened for HBsAg, if mother is found to be HBsAg-positive, give 0.5 mL IM as soon as possible and within 1 week after birth plus appropriate hepatitis B vaccine series. 3.HyperHEP B(R) (perinatal transmission prophylaxis in infants born to HBeAg- or HBsAg-positive mothers) 0.5 mL IM within 12 hours of birth plus appropriate hepatitis B vaccine series; if hepatitis B vaccine is delayed for as long as 3 months, then give hepatitis B immune globulin and repeat at 3 months; if hepatitis B vaccine is refused, then give hepatitis B immune globulin and repeat at 3 and 6 months.
藥動學
approximately 18 hours [16]
禁忌症
Anaphylactic or severe systematic reactions to parenteral human globulin. IgA deficiency; increased risk of anaphylactoid reaction.
懷孕分類
C
哺乳分類
There are no data on the excretion of hepatitis B immune globulin into human milk.
副作用
Common Dermatologic: Erythema at injection site (12% ), Injection site pain (4% ) Gastrointestinal: Nausea (2% to 4% ), Vomiting (2% ) Hematologic: Decreased white blood cell count (Mild) (2% ), Ecchymosis (Mild) (2% ) Hepatic: Alkaline phosphatase raised (Mild) (4% ), AST/SGOT level raised (Mild) (2% ) Musculoskeletal: Joint stiffness (Mild) (2% ), Myalgia (10% ) Neurologic: Headache (14% ) Renal: Serum creatinine raised (Mild) (2% ) Other: Malaise (6% )
劑量和給藥方法
小兒調整劑量
Hepatitis B, Postexposure; Prophylaxis household exposure in infants less than 12 months of age, acute hepatitis B infection in mother or primary caregiver: 0.5 mL IM as a single dose plus hepatitis B vaccine. HepaGam B(R), Nabi-HB(R) (perinatal transmission prophylaxis in infants born to HBsAg-positive mothers) 0.5 mL IM within 12 hours of birth plus appropriate hepatitis B vaccine series ; for infant born to mothers not screened for HBsAg, if mother is found to be HBsAg-positive, give 0.5 mL IM as soon as possible and within 1 week after birth plus appropriate hepatitis B vaccine series. HyperHEP B(R) (perinatal transmission prophylaxis in infants born to HBeAg- or HBsAg-positive mothers) 0.5 mL IM within 12 hours of birth plus appropriate hepatitis B vaccine series; if hepatitis B vaccine is delayed for as long as 3 months, then give hepatitis B immune globulin and repeat at 3 months; if hepatitis B vaccine is refused, then give hepatitis B immune globulin and repeat at 3 and 6 months.
腎功能調整劑量
No adjustment recommended
肝功能調整劑量
No adjustment recommended
安定性
1.Do not shake vial to avoid foaming; do not use if turbid. 2.If dilution is preferred prior to IV administration, dilute with NS; do NOT use D5W. 3.HepaGam B(R) is for single use only; discard unused portions. 4.Store under refrigeration (2 to 8 degrees Celsius; 36 to 46 degrees Fahrenheit); do not freeze. Use Nabi-HB(TM) and HepaGam(TM) within 6 hours after the vial has been entered.
藥袋資訊
臨床用途
預防B型肝炎之感染
主要副作用
泡製方法
儲存方式
請置於 2-8℃ 冷藏儲存
注意事項
其他說明
門診 因藥品低庫存,門診藥局不備庫 藥庫 冰Y13
藥品外觀
顏色
形狀
剝痕
標記1
標記2
其他
健保藥價
2690
自費價
3228
仿單
資料庫
健保給付規定